A scientist specializing in immunology and genetic medicine, he played a pivotal role in developing the world’s first custom gene-editing therapy, with his work featured in The New York Times, CNN, The New England Journal of Medicine, and other international outlets.
Alongside his scientific career, Dr. Kassim has spent 26 years in both formal and informal study of the Islamic tradition across the U.S., U.A.E., Syria, Egypt, and Iraq. He is the founder of the Islamic Message Foundation of New Orleans and co-founder of the Taha Collective in Boston, initiatives that reflect his commitment to spiritual learning and community building.

